Stock Events

Stock Events

Search...

EGF Theramed Health

$0.01

0

-$0.07-87.34% Wednesday 14:31

Statistics

Day High

0.02

Day Low

0.02

52W High

0.3

52W Low

0.01

Volume

535

Avg. Volume

53

Mkt Cap

1.08M

P/E Ratio

-

Dividend Yield

-

Dividend

-

Earnings

31DecExpected

Q1 2017

Q2 2017

Q3 2017

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-5,860.37

-3,900.36

-1,940.35

19.66

Expected EPS

N/A

Actual EPS

-9.5773

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVAHF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Corbus Pharmaceuticals

Corbus Pharmaceuticals works on cannabinoid-based drug development, directly aligning with EGF Theramed Health's focus on cannabis-based health solutions.

Charlotte's Web holdings are well-known for their hemp-derived health products, which places them in direct competition with EGF Theramed Health in the cannabinoid product market.

Tilray produces medical cannabis products, competing in the same space as EGF Theramed Health, particularly in the therapeutic cannabis industry.

Canopy Growth Corporation is a leader in cannabis and cannabinoid-derived products, making them a major competitor in the same industry as EGF Theramed Health.

Aurora Cannabis

Aurora Cannabis is involved in the production and distribution of medical cannabis, directly competing with EGF Theramed Health's cannabis-based medical treatments.

Cresco Labs focuses on cannabis and medical marijuana, competing with EGF Theramed Health in the development and distribution of therapeutic cannabis products.

About

Hospital/Nursing Management

Pharmaceuticals: Major

Health Technology

EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.

Show more...

CEO

Country

CA

ISIN

CA2684692023

Listings